MedPath

Endobronchial Diagnosis of Lymphoma

Not Applicable
Conditions
Lymphoma
Registration Number
NCT05075655
Lead Sponsor
University Hospital, Caen
Brief Summary

The present study aimed to assess the diagnostic performance of ultrasound-guided endobronchial intra-nodal miniforceps biopsy (EBUS-MFB) in the diagnosis of "de novo" mediastinal lymphoma.

Detailed Description

Every patients will be sampled using both EBUS-MFB and the standard of care EBUS-TBNA (transbronchial needle aspiration).

It is a monocentric investigation. Pathologist will not know the way of sampling while analysing the samples

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
33
Inclusion Criteria
  • Pathological mediastinal nodes within reach of EBUS sampling on CT-scan.
  • Lymphoma suspicion by a senior clinical hematologist
  • Affiliated to the french public health care insurance
Exclusion Criteria
  • Peripherical pathological lymph nodes reachable without general anesthesia
  • Antithrombotic medication that cannot be stopped le time of the procedure.
  • Unstable respiratory status
  • History of lymphoma
  • Latex or xylocaine allergia

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Primary Outcome Measures
NameTimeMethod
positivity of the procedure in Diagnosis and Subtyping of lymphomaup to 3 years

a sample wil be considered positive if it allows the clinical management of the patient, without additional sampling required.

Secondary Outcome Measures
NameTimeMethod
every adverse effect related to the procedureup to 3 years

infectious process related to the procedure, hemoptysis over 50cc, worsening of respiratory status requiring hospitalization

Trial Locations

Locations (1)

CaenUH

🇫🇷

Caen, Normandy, France

CaenUH
🇫🇷Caen, Normandy, France
Dutheil M Jean-Jacques
Contact
0231065351
dutheil-jj@chu-caen.fr

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.